Piperacillin 4 gm plusTazobactam 500 mg Inj,Tigecycline 50 mg powder for injection,Gentamycin sulph
Other · open
Key facts
- Closing date: 17 Aug 2026
- Status: open
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
Commercial terms
- Make in India (MII): No
- MSE preference: No
1 tender document(s) available — sign up to download.